Market attention is focused on NeOnc Technologies Holdings due to positive clinical trial results and discussions regarding the path toward a registrational study.

The entities involved

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• FDA issued a partial clinical hold on trials involving Biohaven Ltd. on September 11, 2026.Sep 12
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• FDA placed a clinical hold on Phase 2/3 trials for SK Biopharm on September 1, 2026.Sep 15
• Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.Aug 5